methylprednisolone and Movement Disorders

methylprednisolone has been researched along with Movement Disorders in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19903 (16.67)18.7374
1990's3 (16.67)18.2507
2000's3 (16.67)29.6817
2010's8 (44.44)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Aarabi, B; Badhiwala, JH; Fehlings, MG; Geisler, FH; Grossman, RG; Harrop, JS; Vaccaro, AR; Wilson, JR; Witiw, CD1
Goenka, A; Jain, V; Nariai, H; Spiro, A; Steinschneider, M1
Armangue, T; Cantarín-Extremera, V; Duat-Rodríguez, A; González-Gutiérrez-Solana, L; López-Marín, L1
Garcia-Estevez, DA1
Abdool, K; Dyaanand, H; Persad, N; Ramcharan, K1
Fernandes, J; Ferreira, C; Machado, A; Rocha, J; Rodrigues, M1
Kitazawa, Y; Koide, R; Kuroda, M; Tanaka, K; Uruha, A1
Della Giustina, E; Frattini, D; Fusco, C; Pisani, F; Ucchino, V1
Bandeira, M; Borlot, F; Kok, F; Liberalesso, PB; Löhr, A; Reed, UC; Santos, ML1
Borlongan, CV; Hess, DC; Yu, G1
Chiba, J; Ishigatsubo, Y; Kato, K; Nagaoka, S; Nose, K; Okubo, T; Sakamoto, H; Tani, K1
Caglar, M; Ersoy, F; Gunay, M; Gurgey, A; Kale, G; Kucukali, T; Sayli, T1
del Olmo, A; González, A; Taberner, P; Tornero, C1
Blunt, SB; Lane, RJ; Perkin, GD; Turjanski, N1
Abe, K; Kashihara, K; Marui, K; Takahashi, K; Tanimoto, Y1
Chikawa, T; Fukuzawa, K; Hamada, Y; Ikata, T; Katoh, S; Kogure, K1
Oldham, R; Roy, S1
Ducker, TB; Hamit, HF1

Other Studies

18 other study(ies) available for methylprednisolone and Movement Disorders

ArticleYear
The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data.
    The Lancet. Neurology, 2021, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cervical Vertebrae; Decompression, Surgical; Disability Evaluation; Endpoint Determination; Female; Humans; Male; Methylprednisolone; Middle Aged; Movement Disorders; Neurosurgical Procedures; Prospective Studies; Recovery of Function; Sensation; Spinal Cord Injuries; Time-to-Treatment; Treatment Outcome; Young Adult

2021
Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.
    Pediatric neurology, 2017, Volume: 72

    Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Child, Preschool; Disease Progression; Female; Hallucinations; Humans; Immunoglobulins, Intravenous; India; Infant; Male; Methylprednisolone; Movement Disorders; Seizures; Sleep Initiation and Maintenance Disorders; Symptom Assessment; Treatment Outcome; Young Adult

2017
Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder.
    Pediatric neurology, 2013, Volume: 48, Issue:5

    Topics: Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Deglutition Disorders; Humans; Hyperkinesis; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Movement Disorders; Prednisone; Psychomotor Agitation; Stupor; Tetrabenazine; Treatment Outcome

2013
[Cervicodorsal myelitis secondary to infection by varicella zoster virus in an immunocompetent patient].
    Revista de neurologia, 2013, Aug-16, Volume: 57, Issue:4

    Topics: Acyclovir; Antiviral Agents; Arm; Athetosis; Bromodeoxyuridine; Drug Therapy, Combination; Herpes Zoster; Herpesvirus 3, Human; Humans; Hyperalgesia; Immunocompetence; Male; Methylprednisolone; Middle Aged; Movement Disorders; Myelitis; Neck; Neuralgia, Postherpetic; Somatosensory Disorders; Thorax; Virus Activation

2013
Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.
    BMJ case reports, 2015, May-07, Volume: 2015

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Movement Disorders; Mycophenolic Acid; Prednisolone

2015
The groom who could not say "I do".
    Practical neurology, 2010, Volume: 10, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Cranial Nerve Diseases; Facial Asymmetry; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Oligoclonal Bands; Prednisone

2010
Anti-NMDAR encephalitis in small-cell lung cancer: a case report.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:3

    Topics: Acyclovir; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antimetabolites; Fatal Outcome; Humans; Lung Neoplasms; Male; Mental Disorders; Meropenem; Methylprednisolone; Movement Disorders; Small Cell Lung Carcinoma; Thienamycins

2012
Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4

    Topics: Adrenal Cortex Hormones; Age of Onset; Anti-Inflammatory Agents; Anticonvulsants; Antipsychotic Agents; Antistreptolysin; Child; Chorea; Deglutition; Female; Humans; Male; Mastication; Methylprednisolone; Movement Disorders; Myocarditis; Neurologic Examination; Paralysis; Pregnenediones; Rheumatic Fever

2012
Anti-N-methyl D-aspartate receptor encephalitis in childhood.
    Jornal de pediatria, 2012, Volume: 88, Issue:3

    Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Immunosuppression Therapy; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Seizures; Speech Disorders

2012
Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
    Brain research, 2004, Aug-20, Volume: 1018, Issue:1

    Topics: Animals; Brain Ischemia; Cerebral Infarction; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome

2004
[A case of systemic lupus erythematosus with akinesia, muscle rigidity and neurogenic bladder].
    Ryumachi. [Rheumatism], 1984, Volume: 24, Issue:5

    Topics: Adult; Antiparkinson Agents; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Movement Disorders; Muscle Rigidity; Urinary Bladder, Neurogenic

1984
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement.
    American journal of hematology, 1994, Volume: 47, Issue:4

    Topics: Albinism; Central Nervous System Diseases; Child; Etoposide; Female; Fever; Humans; Leukopenia; Methylprednisolone; Movement Disorders; Syndrome; Thrombocytopenia

1994
[Mixed polyneuropathy as a form of presentation of serologically AACN-P positive microscopic panarteritis].
    Neurologia (Barcelona, Spain), 1994, Volume: 9, Issue:1

    Topics: Aged; Arthritis; Aspirin; Autoantibodies; Blood Chemical Analysis; Cytoplasm; Diagnosis, Differential; Electromyography; Female; Humans; Methylprednisolone; Movement Disorders; Neutrophils; Vasculitis

1994
Clinical features and management of two cases of encephalitis lethargica.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:3

    Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Encephalitis; Female; Humans; Injections, Intravenous; Methylprednisolone; Movement Disorders; Myoclonus; Sleep Stages

1997
Inflammatory demyelinating polyradiculoneuropathy associated with interstitial lung disease.
    Clinical rheumatology, 2000, Volume: 19, Issue:3

    Topics: Anti-Inflammatory Agents; Female; Guillain-Barre Syndrome; Humans; Lung; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Movement Disorders; Radiography, Thoracic; Recurrence; Sensation Disorders; Tomography, X-Ray Computed

2000
Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes.
    Journal of neurotrauma, 2001, Volume: 18, Issue:1

    Topics: Animals; Gene Expression Regulation; Glycerol-3-Phosphate Dehydrogenase (NAD+); Glycerolphosphate Dehydrogenase; Intercellular Adhesion Molecule-1; Interleukin-1; Male; Methylprednisolone; Movement Disorders; Myelitis; Nerve Growth Factors; Neurotrophin 3; Nitric Oxide Synthase; Phosphatidylcholines; Rats; Rats, Wistar; Recovery of Function; RNA, Messenger; Spinal Cord Injuries; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Transcription, Genetic

2001
Management of painful shoulder.
    Lancet (London, England), 1976, Jun-19, Volume: 1, Issue:7973

    Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Male; Methylprednisolone; Middle Aged; Movement Disorders; Pain; Shoulder Joint; Syndrome

1976
Experimental treatments of acute spinal cord injury.
    Journal of neurosurgery, 1969, Volume: 30, Issue:6

    Topics: Acute Disease; Animals; Dexamethasone; Dogs; Edema; Female; Gelatin Sponge, Absorbable; Hypothermia, Induced; Injections, Intramuscular; Injections, Spinal; Male; Methylprednisolone; Movement Disorders; Spinal Cord; Spinal Cord Injuries

1969